Publications
Review Article
Progress in the development of a therapeutic vaccine for breast cancer
Cancer Vaccines
2010
Authors:
Coveler, A.L. Bates, N.E., Disis, M.L.
Journal:
Breast Cancer (Dove Press)
Volume:
2
Page:
25-36
Original Article
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102
Cancer Vaccines
2010
Authors:
Karyampudi, L., Formicola, C., Erskine, C. L., Maurer, M. J., Ingle, J. N., Krco, C. J., Wettstein, P. J., Kalli, K. R., Fikes, J. D., Beebe, M., Hartmann, L. C., Disis, M. L., Ferrone, S., Ishioka, G., Knutson, K. L.
Journal:
Clinical Cancer Research
Volume:
16(3)
Page:
825-34
Review Article
Immunomodulation of breast cancer via tumor antigen specific Th1
Cancer Vaccines
2009
Authors:
Disis M.L., Park K.H.
Journal:
Cancer Research Treatment
Volume:
41(3)
Page:
117-21
Original Article
Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer
Cancer Vaccines
2009
Authors:
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA, Dela Rosa C, Tietje K, Link J, Waisman J, Salazar LG.
Journal:
Journal of Clinical Oncology
Volume:
27(28)
Page:
4685-92
Original Article
In situ adenovirus vaccination engages T effector cells against cancer
Cancer Vaccines
2009
Authors:
Tuve S, Liu Y, Tragoolpua K, Jacobs JD, Yumul RC, Li ZY, Strauss R, Hellstrom KE, Disis ML, Roffler S, Lieber A.
Journal:
Vaccine
Volume:
27(31)
Page:
4225-39
Original Article
Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity
Cancer Vaccines
2009
Authors:
Coveler AL, Goodell V, Webster DJ, Salazar LG, Fintak PA, Childs JS, Higgins DM and Disis ML
Journal:
Breast Cancer Research and Treatment
Volume:
113(1)
Page:
95-100
Original Article
Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer
Cancer Vaccines
2008
Authors:
Park KH, Gad E, Goodell V, Dang Y, Wild T, Higgins D, Fintak P, Childs J, Dela Rosa C, Disis ML
Journal:
Cancer Research
Volume:
68(20)
Page:
8400-9
Original Article
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity
Cancer Vaccines
2008
Authors:
Goodell V, Waisman J, Salazar LG, dela Rosa C, Link J, Coveler AL, Webster W, Childs JS, Fintak PA, Higgins DM and Disis ML
Journal:
Molecular Cancer Therapeutics
Volume:
7(3)
Page:
449-54
Original Article
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer
Cancer Vaccines
2008
Authors:
Kalli KR, Krco CJ, Hartmann LC, Goodman K, Maurer MJ, Yu C, Johnson EM, Erskine CL, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, Knutson KL
Journal:
Cancer Research
Volume:
68(12)
Page:
4893-901
Original Article
Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancers
Cancer Vaccines
2007
Authors:
Salazar LG, Coveler AL, Swensen RE, Gooley TA, Goodell V, Schiffman K and Disis ML
Journal:
Clinical Immunology
Volume:
125(3)
Page:
275-80